Ask the Experts
Dr. Helen Baker has over 15 years of formulation and product development experience within the pharmaceutical, biotech, and agronomical industries.
Helen has expertise in the formulation of poorly soluble and bioavailable, amorphous, and physically and chemically labile compounds.
Prior to her role at Quotient Sciences, Helen managed numerous formulation development, plant scale-up, and R&D endeavours across multiple industries.
In this article, Dr. Baker discusses how understanding critical attributes earlier in development can lead to a more robust drug product. Helen gives details on the clinical testing and development processes available under one roof at Quotient Sciences.